Showing results (2461-2470 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 12, 2011
The risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysisYevgeniy Balagula, Shenhong Wu, Xiao Su, et al.
Investigational New Drugs|June 15, 2011
The role of CXCR2 chemokine receptors in the oral squamous cell carcinomaJuliana Romanini, Tânia R Mielcke, Paulo C Leal, et al.
Investigational New Drugs|June 15, 2011
Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancerJean-Philippe Spano, Malcolm J Moore, Yazdi K Pithavala, et al.
Investigational New Drugs|May 17, 2011
Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrestWon Ki Kim, Ju-Hwa Kim, Kyungsil Yoon, et al.
Investigational New Drugs|June 17, 2011
Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemiaDarya Habibi, Nadya Ogloff, Reza B Jalili, et al.
Investigational New Drugs|September 7, 2011
Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancerYasuhide Yamada, Tatsuro Yamaguchi, Hiroshi Matsumoto, et al.
Investigational New Drugs|July 6, 2011
Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosisJames L Figarola, Yehua Weng, Christopher Lincoln, et al.
Investigational New Drugs|October 22, 2011
Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumorsThomas J Semrad, Courtney Eddings, Chong-Xian Pan, et al.
Investigational New Drugs|October 18, 2011
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126Auke D Adema, Kees Smid, Nienke Losekoot, et al.
Investigational New Drugs|January 1, 1995
Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitroH Depenbrock, A Shirvani, J Rastetter, et al.
Pageof 372